Related Experiment Video
Updated: Jun 10, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
Quality of life in sarcoidosis: assessment and management
Jolanda De Vries1, Elyse E Lower, Marjolein Drent
1CoRPS, Department of Medical Psychology and Neuropsychology, Tilburg University, Tilburg, The Netherlands. j.devries@uvt.nl
Abstract:
This review focuses on current knowledge of the QOL (quality of life) and HS (health status) of sarcoidosis patients. The QOL and HS of sarcoidosis patients are impaired and symptoms are a cause of this impairment. Fatigue appears to be the major problem in sarcoidosis patients. QOL is a concept that concerns patients' evaluation of their functioning in a wide range of domains, but always the physical, psychological, and social domain. HS concerns patients' physical, psychological, and social functioning. There are a number of HS questionnaires and one QOL measure that have shown useful in sarcoidosis. In addition, there exists one sarcoidosis-specific HS measure. The main symptom of fatigue can be assessed reliably and valid with the Fatigue Assessment Scale. The absence of objective parameters for experiencing impairment does not always mean that patients are healthy. Because what patients can handle is clearly decreased, the activities should be adapted accordingly. Present studies are generally cross-sectional. There is a need for prospective follow-up studies assessing the natural course of patients' disease in relation to symptoms and QOL.
More Related Videos
Related Concept Videos
COPD: Management Using Bronchodilators and Corticosteroids
Cardiomyopathy VI: Nursing Management
Chronic Obstructive Pulmonary Disease-V: Management
Smoking Cessation
Nephrotic Syndrome II : Assessment and Medical Management
Rheumatic Heart Disease IV: Nursing Management
Myocarditis IV: Nursing Management
